Skip to main content

Security report for microvention.com

Terumo Neuro · Healthcare · N/a

Low risk. 4 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

77/100

Risk levelLow

0–100, higher is better. How it is calculated

Terumo Neuro is a specialized medical device company focused on innovative neurovascular solutions for the treatment and prevention of hemorrhagic and ischemic strokes. As a wholly owned subsidiary of Terumo Corporation, it leverages robust clinical data and advanced technology to serve healthcare professionals primarily in the European Union. The website reflects a mature digital presence with comprehensive product information, educational resources, and compliance documentation tailored for its professional audience. Technically, the website is built on modern frameworks such as Next.js and React, incorporating video content and cookie consent mechanisms to enhance user engagement and privacy compliance. The site demonstrates good performance, mobile optimization, and accessibility standards, contributing to a positive user experience. From a security perspective, the site enforces HTTPS, implements key security headers, and integrates GDPR-compliant cookie consent. However, the absence of WHOIS data and direct contact information for security or incident response limits full trust verification. No critical vulnerabilities or security issues were detected in the content. Overall, the website presents a professional and trustworthy front for Terumo Neuro, though domain registration transparency should be improved to enhance legitimacy assurance. Strategic recommendations include publishing explicit security policies, incident response contacts, and vulnerability disclosure channels to strengthen security posture and stakeholder trust.

Scanned

This is an earlier scan of microvention.com. View the latest report

NIS2 and GDPR posture

GDPR outside view
53/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching microvention.com

This scan found 18 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
80
Email security
70
DNS health
85
Network security
100
GDPR outside view
53
Average
77

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Terumo Neuro operates in the healthcare sector, focusing on neurovascular medical devices. Its market positioning is strong as a global player backed by Terumo Corporation. The business model centers on manufacturing and distributing specialized medical devices to healthcare professionals, supported by clinical education and compliance resources. The company targets healthcare providers in the EU, excluding France for some content due to regulatory reasons. The website indicates a large enterprise scale with a consistent brand and high-quality content. Partnerships and parent company relationships are clearly referenced, enhancing credibility. Growth indicators include active news updates, events participation, and multimedia educational content.

Security posture

The website exhibits a mature security posture with enforced HTTPS, comprehensive security headers, and GDPR-compliant cookie consent mechanisms. No exposed sensitive data or vulnerable libraries were identified. However, the lack of a dedicated security policy page, incident response information, and vulnerability disclosure mechanisms represents a compliance gap. The absence of WHOIS data reduces domain trust verification. Overall, the security maturity is good but can be enhanced by adding explicit security governance documentation and direct security contact channels.

Recommendations

  1. Publish a dedicated security policy and incident response page to improve transparency.
  2. Implement a security.txt file or vulnerability disclosure program to facilitate responsible reporting.
  3. Provide direct security contact emails (e.g., security@terumoneuro.com) for incident reporting.
  4. Regularly audit third-party scripts and dependencies to mitigate supply chain risks.
  5. Enhance domain registration transparency by ensuring WHOIS data is publicly available or justified if privacy protected.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Terumo Neuro
Description
Terumo Neuro offers advanced neurovascular solutions for brain aneurysms, ischemic stroke, and related conditions, focusing on improving patient outcomes with cutting-edge medical devices.
Key services
Hemorrhagic stroke treatment devices, Ischemic stroke treatment devices, Access products including catheters and guidewires, Clinical education and compliance resources
Content quality
excellent
Branding
consistent

Technology

Stack
React, Next.js, Video.js, OneTrust Cookie Consent, CSS Modules
Frameworks
Next.js
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
90/100
Good practices seen
  • HTTPS enforced
  • Cookie consent implemented
  • No exposed sensitive data in HTML
  • Use of security headers

Analytics and tracking

Tracking level
minimal
Privacy practices
good

Advertising

Tracking pixels
OneTrust
Marketing tools
OneTrust Cookie Consent
Transparency
basic

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website targets healthcare professionals in the EU with neurovascular medical devices.
  2. Content is rich, professional, and well-structured with clear navigation.
  3. Strong compliance focus with privacy and cookie policies and GDPR consent mechanisms.
  4. No direct contact emails or phone numbers found; contact is via form.
  5. No WHOIS data available, which is unusual and warrants further investigation.
  6. No signs of WAF or blocking; site fully accessible.
  7. Use of modern web technologies and video content enhances user engagement.
Technical notes

Notes

The website is built using modern web technologies including React and Next.js, enabling server-side rendering and improved SEO. It uses Video.js for multimedia content and OneTrust for cookie consent management, reflecting compliance with privacy regulations. The site is mobile optimized and accessible, with good SEO practices such as meta tags and Open Graph data. Performance is moderate, with room for optimization in image loading and script management. No CMS was detected, suggesting a custom or headless architecture. Hosting provider details are not explicit. Overall, the technical infrastructure supports a professional and engaging user experience with opportunities for further performance tuning.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 76/100Low28 findingsView report
Reviews of this site

Share your experience with microvention.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review microvention.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.